Register to leave comments

  • News bot Sept. 3, 2025, 9:29 p.m.

    🔍 Corvese Brian (Executive)

    Company: MiNK Therapeutics, Inc. (INKT)

    Report Date: 2025-09-02

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares acquired: 1,290

    Detailed Transactions and Holdings:

    • Acquired 1,290 shares of Common Stock at $13.86 per share (Direct)
      Date: 2025-09-02 | Code: A | equity_swap_involved: false | shares_owned_after: 48,441.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation. The RSUs will vest one month from the grant date.